{
    "id": 12998,
    "fullName": "TTK I531M",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TTK I531M lies within the ATP-binding region in the protein kinase domain of the Ttk protein (UniProt.org). I531M confers resistance to Ttk (Mps1) inhibitors by preventing binding to the Ttk protein, but otherwise has activity similar to wild-type (PMID: 26202014).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7272,
        "geneSymbol": "TTK",
        "terms": [
            "TTK",
            "CT96",
            "ESK",
            "MPH1",
            "MPS1",
            "MPS1L1",
            "PYT"
        ]
    },
    "variant": "I531M",
    "createDate": "10/08/2015",
    "updateDate": "10/24/2019",
    "referenceTranscriptCoordinates": {
        "id": 122109,
        "transcript": "NM_003318",
        "gDna": "chr6:g.80031538A>G",
        "cDna": "c.1593A>G",
        "protein": "p.I531M",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4669,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colon cancer cell lines expressing TTK I531M were resistant to inhibition by CCT251455 (PMID: 26202014).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3118,
                "therapyName": "CCT251455",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4659,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In preclinical studies, colon cancer cell lines expressing TTK I531M were resistant to inhibition by AZ3146 in culture (PMID: 26202014, PMID: 26364596).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3117,
                "therapyName": "AZ3146",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4664,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In preclinical studies, colon cancer cell lines expressing TTK I531M were resistant to inhibition by NMS-P715 (PMID: 26202014, PMID: 26364596).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3107,
                "therapyName": "NMS-P715",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4677,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colon cancer cell lines expressing Ttk (Mps1) I531M were sensitive to inhibition by SNG12 in culture (PMID: 26202014).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3593,
                "therapyName": "SNG12",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4679,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colon cancer cell lines expressing TTK I531M were resistant to inhibition by ONCOII in culture (PMID: 26202014).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3594,
                "therapyName": "ONCOII",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3711,
                    "pubMedId": 26202014,
                    "title": "Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26202014"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4692,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK I531M was resistant to inhibition by Cpd-5 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 13159,
                "profileName": "TTK I531M"
            },
            "therapy": {
                "id": 3465,
                "therapyName": "Cpd-5",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13159,
            "profileName": "TTK I531M",
            "profileTreatmentApproaches": [
                {
                    "id": 7879,
                    "name": "SNG12",
                    "profileName": "TTK I531M"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 122109,
            "transcript": "NM_003318",
            "gDna": "chr6:g.80031538A>G",
            "cDna": "c.1593A>G",
            "protein": "p.I531M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122110,
            "transcript": "XM_011536099",
            "gDna": "chr6:g.80031538A>G",
            "cDna": "c.1593A>G",
            "protein": "p.I531M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122108,
            "transcript": "XM_017011242",
            "gDna": "chr6:g.80035128C>G",
            "cDna": "c.1593C>G",
            "protein": "p.I531M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}